Metabotropic glutamate receptors (mGluRs) 1-8 are G proteincoupled receptors (GPCRs) that modulate excitatory neurotransmission, neurotransmitter release, and synaptic plasticity. PKC regulates many aspects of mGluR function, including protein-protein interactions, Ca 2؉ signaling, and receptor desensitization. However, the mechanisms by which PKC regulates mGluR function are poorly understood. We have now identified calmodulin (CaM) as a dynamic regulator of mGluR5 trafficking. We show that the major PKC phosphorylation site on the intracellular C terminus of mGluR5 is serine 901 (S901), and phosphorylation of this residue is up-regulated in response to both receptor and PKC activation. In addition, S901 phosphorylation inhibits mGluR5 binding to CaM, decreasing mGluR5 surface expression. Furthermore, blocking PKC phosphorylation of mGluR5 on S901 dramatically affects mGluR5 signaling by prolonging Ca 2؉ oscillations. Thus, our data demonstrate that mGluR5 activation triggers phosphorylation of S901, thereby directly linking PKC phosphorylation, CaM binding, receptor trafficking, and downstream signaling.
T
he group I metabotropic glutamate receptor mGluR5 is highly expressed in the forebrain, where it regulates synaptic plasticity (1, 2) . In addition, mGluR5 plays a role in pain (3) and addiction (4) and in neurological disorders such as fragile X syndrome (5, 6) . Group I mGluRs are G protein-coupled receptors (GPCRs), which are coupled to phospholipase C, and receptor activation triggers phosphoinositide turnover, release of intracellular Ca 2ϩ , and activation of Protein Kinase C (PKC) (7) . Although PKC activity regulates mGluR5-mediated Ca 2ϩ signaling and receptor function (8) (9) (10) (11) , there are no studies linking PKC phosphorylation of mGluR5 to receptor surface expression, endocytosis, or intracellular trafficking.
Like other GPCRs, mGluR5 interacts with many proteins in addition to the guanine nucleotide-binding proteins (G proteins). Most of the binding sites for these protein-protein interactions reside within the long intracellular C-terminal domain of mGluR5, suggesting that this region is critical in the functional regulation of mGluR5. For example, the Homer proteins bind to the PPxxFR motif within the distal C terminus, the Tamalin protein associates with the distal C terminus, and calmodulin (CaM) and the E3 ligase Siah-1A bind to the first one-third of the mGluR5 C terminus (12) (13) (14) (15) . However, the dynamic regulation of these protein-protein interactions has not been described. CaM is a particularly intriguing candidate as an mGluR5 regulator because of its Ca 2ϩ dependence and its key role in synaptic plasticity (16, 17) . Furthermore, CaM binding to other GPCRs, including dopamine, opioid, and serotonin receptors, has been documented, consistent with a conserved regulatory role for CaM in regulating GPCRs (18) (19) (20) . We now show that PKC phosphorylation of serine 901 (S901) on mGluR5 inhibits CaM binding and decreases mGluR5 surface expression. Furthermore, preventing S901 phosphorylation led to a dramatic increase in mGluR5-mediated Ca 2ϩ oscillations, revealing a direct mechanistic link among mGluR5 activation, phosphorylation, trafficking, and downstream signaling.
Results
We characterized the direct phosphorylation of mGluR5 by PKC by using several biochemical techniques. GST fusion proteins containing the proximal one-third of the mGluR5 C terminus (GST-mGluR5-Cprox) were incubated with purified PKC in vitro, and receptor phosphorylation was evaluated by using phosphopeptide map analysis. There were multiple PKC phosphorylation sites, and mutation of S901 to alanine eliminated the most prominent phosphopeptides, indicating that S901 is directly phosphorylated by PKC (Fig. 1A) . We also evaluated the phosphorylation of GST-mGluR5-Cprox by PKC by using mass spectrometry, which unambiguously identified S901 as the predominant phosphorylation site (data not shown). HeLa cells expressing Myc-tagged wild-type mGluR5 or mGluR5 S901A were treated with the PKC activator phorbol 12-myristate 13-acetate (PMA), and we observed phosphorylation of wild-type mGluR5, but not mGluR5 S901A, by using a S901 phosphorylation state-specific antibody. Treating the cells with PMA to stimulate PKC rapidly increased the phosphorylation of mGluR5 on S901 ( Fig. 1 B and C) . Furthermore, application of the mGluR5 agonist dihydroxyphenylglycol (DHPG) dramatically increased S901 phosphorylation on mGluR5 in heterologous cells ( Fig. 1 D and E) . To examine S901 phosphorylation of endogenous mGluR5, phosphorylated receptor was immunoprecipitated from cell lysates prepared from cultured hippocampal neurons by using the S901 phosphorylation state-specific antibody in both nondenaturing and denaturing conditions. We found that PKC activation increased S901 phosphorylation of mGluR5 in hippocampal neurons (Fig. 1 F and G) . In addition, DHPG increased S901 phosphorylation, which was blocked by the PKC inhibitor bisindolylmaleimide I, demonstrating that agonist-induced S901 phosphorylation is mediated by PKC ( Fig.  1 H-J) . S901 is located within a region of the mGluR5 C terminus that contains a CaM-binding site (Fig. 2 A) , and previous studies have shown that the CaM-mGluR5 interaction is regulated by PKC phosphorylation in vitro (21) . We, therefore, evaluated CaM binding to the mGluR5 C terminus by using a GST pull-down assay. As anticipated, wild-type mGluR5 bound to CaM robustly, and the interaction was disrupted by PKC phosphorylation (Fig. 2 A) . However, PKC-dependent inhibition of CaM binding to mGluR5 was eliminated when S901 on mGluR5 was mutated to alanine ( Fig.  2 A) , highlighting a central role for S901 in regulating CaM binding to mGluR5. The CaM-mGluR5 interaction is abolished by the addition of EGTA to the binding reaction mixture, indicating that it is Ca 2ϩ -dependent ( Fig. 2A) . We also performed coimmunoprecipitation experiments by using full-length mGluR5 and CaM expressed in HeLa cells, and we found that mutation of S901 to aspartic acid, a phosphomimetic mutation of S901, profoundly Statistical significance is indicated as ** (P Ͻ 0.01).
inhibited mGluR5 binding to CaM (Fig. 2B) . Thus, these findings identify phosphorylation of S901 as the critical mechanism regulating mGluR5 binding to CaM.
We next directly examined the role of PKC phosphorylation and CaM binding on the trafficking of mGluR5. We monitored the trafficking of mGluR5 at or near the plasma membrane in real time by using total internal reflection fluorescence microscopy (TIRFM) (Fig. 3A) . Fluorescent spots of mGluR5-monomeric red fluorescent protein (mRFP) moved away from the plasma membrane after agonist treatment, consistent with agonist-induced endocytosis. In contrast to wild-type mGluR5, the distribution of mGluR5 S901A did not change significantly over time (Fig. 3B) . By using an ELISA-based assay, we found that the surface expression of wildtype mGluR5 decreased over time with agonist exposure, whereas the surface expression of mGluR5 S901A did not (Fig. 3C) . Therefore, our findings support a role for S901 phosphorylation in regulating mGluR5 trafficking and surface expression. To mimic S901 phosphorylation of the entire pool of mGluR5, we mutated S901 to aspartic acid, a phosphomimetic mutation, and measured surface expression of wild-type mGluR5 and mGluR5 S901D by using a biotinylation assay. Compared to wild-type mGluR5, the surface level of mGluR5 S901D was dramatically decreased (Fig. 3D) .
Because S901 regulates binding of CaM, we explored whether changes in CaM expression altered mGluR5 surface expression. Although overexpression or knockdown of CaM did not affect the steady-state surface expression level of mGluR5 (Fig. 3E) , overexpression of CaM inhibited agonist-induced changes in mGluR5 surface expression (Fig. 3F) . Furthermore, knockdown of CaM by using shRNA CaM decreased the surface expression of mGluR5 S901A after agonist exposure (Fig. 3G) , a finding that was consistent with the mGluR5 S901A effects on trafficking being a direct result of increased CaM binding to the receptor.
We also examined the role of S901 phosphorylation and CaM binding on the trafficking of mGluR5 expressed in hippocampal neurons. By using a fluorescence-based antibody uptake assay, we observed robust endocytosis (internalized receptor, green) and a concomitant reduction in surface-expressed wild-type mGluR5 (surface, red) with agonist treatment (Fig. 4A) . We found a significant decrease in the amount of internalized mGluR5 S901A compared to wild-type mGluR5 (Fig. 4 B and C) . In addition, cotransfection of mGluR5 with CaM resulted in a significant decrease in mGluR5 endocytosis, for both wild-type mGluR5 and mGluR5 S901A (Fig. 4 B and C) . These findings demonstrate that mGluR5 trafficking is regulated by S901 phosphorylation and CaM binding in both heterologous cells and in neurons. mGluR5 activation triggers Ca 2ϩ oscillations after agonist treatment, and the frequency of the Ca 2ϩ spikes is correlated with mGluR5 receptor density on the plasma membrane (8, 22) . Therefore, regulation of mGluR5 surface expression by S901 phosphorylation is likely to affect mGluR5-initiated signaling. To test this hypothesis, HeLa cells expressing mGluR5 (wild-type or S901A) were loaded with fura-2-AM, and agonist-simulated Ca 2ϩ oscillation patterns were analyzed by using a ratiometric spectrofluorophotometer. Compared to wild-type mGluR5, mGluR5 S901A showed an increase in Ca 2ϩ oscillation frequency (14.27 Ϯ 3.49 mHz for wild-type vs. 26.75 Ϯ 7.70 mHz for S901A; P Ͻ 0.01) (Fig.  5A and B) . The half-time for Ca 2ϩ to return to prestimulated levels was also measured, revealing that mGluR5 S901A activation resulted in more prolonged Ca 2ϩ oscillations compared to wild-type mGluR5 (151.54 Ϯ 112.83 s for wild-type vs. 886.85 Ϯ 236.97 s for S901A; P Ͻ 0.01) (Fig. 5C ). These data, therefore, demonstrate that mGluR5 S901A-induced signaling is prolonged relative to that observed in wild-type mGluR5-expressing cells.
Discussion
In this study, we have identified S901 as the major PKC phosphorylation site on the intracellular C terminus of mGluR5. Phosphorylation of S901 was dynamically regulated by PKC activity and receptor activation. Importantly, we found that phosphorylation of S901 profoundly inhibited CaM binding to mGluR5. In addition, we found that PKC phosphorylation of S901 decreased mGluR5 surface expression, providing the first evidence that PKC activation directly regulates mGluR5 trafficking. Furthermore, we show that overexpression of CaM increases mGluR5 surface expression, whereas knockdown of CaM decreases mGluR5 surface expression, demonstrating that CaM specifically mediates the PKC-dependent regulation of mGluR5 trafficking. Thus, we show that CaM stabilizes the surface expression of a GPCR. Our findings are consistent with a model in which mGluR5 surface expression is stabilized by CaM binding, but after receptor stimulation, PKC activity increased S901 phosphorylation, disrupted CaM binding, and reduced mGluR5 surface expression (Fig. 6 ).
CaM interacts with a variety of proteins and, via these interactions, regulates neuronal processes such as ion channel function (23, 24) , GPCR signaling (18) (19) (20) 25) , and synaptic plasticity (23) (24) (25) . CaM has been shown to bind to several GPCRs (18) (19) (20) (21) (26) (27) (28) , and in some cases, CaM is implicated in the regulation of GPCR trafficking. For example, agonist-induced endocytosis of the 5-HT 1A receptor is prevented by pharmacological inhibitors of CaM (29) . In addition, CaM regulates the activity of G protein- coupled receptor kinases, which play important roles in endocytosis of GPCRs, suggesting an indirect role of CaM in regulating GPCR trafficking (30, 31) . Recent findings also show that CaM binding to mGluR7 disrupts its interaction with the PDZ protein PICK1, increasing mGluR7 endocytosis (32) . We now describe the direct stabilization of mGluR5 surface expression via CaM binding, and these data are, to our knowledge, the first to describe the dynamic regulation of GPCR trafficking by CaM binding in live cells.
PKC regulates many aspects of mGluR5 function. Early studies have demonstrated that mGluR5 activity elicits high-frequency Ca 2ϩ oscillations that are PKC-dependent. These oscillations are regulated by the direct phosphorylation of the mGluR5 C terminus, with phosphorylation of S839 being required (8, 10) . We now show that phosphorylation of a second site, S901, is a key mechanism in the regulation of mGluR5-mediated high-frequency Ca 2ϩ oscillations. These data strongly suggest that the effect of PKC phosphorylation of S901 on Ca 2ϩ oscillations is mediated by phosphorylationdependent decreases in mGluR5 surface expression.
CaM interacts with ionotropic glutamate receptors in addition to mGluRs. CaM binding to NMDA receptors regulates both receptor localization and channel function, thereby contributing to the modulation of synaptic plasticity (17, 23, 24, 33, 34) . CaM binding to receptors often competes with other protein-protein interactions, and CaM competition with spectrin, and ␣-actinin binding to NMDA receptors is one such example (17, 24, 33, 34) . Similarly, it has also been shown that CaM binding to mGluR5 inhibits the binding of the E3 ligase Siah-1A in vitro (13) . Recently Siah-1A has been shown to promote monoubiquitination of ␣-synuclein, leading to its aggregation (35) . It is possible that the effects of CaM on mGluR5 trafficking observed in our study are a consequence of changes in Siah-1A-dependent ubiquitination of mGluR5; however, direct evidence for this hypothesis awaits further experimentation.
Our findings suggest that the ability of CaM to regulate the binding activities of glutamate receptor-interacting proteins at excitatory synapses may allow it to act as a signal integrator or modulator of glutamate receptor-induced synaptic plasticity. As we now show for mGluR5, the rapid Ca 2ϩ -dependent regulation of CaM binding mediates receptor expression at synapses and will likely regulate mGluR5-dependent processes in vivo as well.
Methods
Detailed information on TIRFM, DNA constructs, antibodies, and additional methods is available in supporting information (SI) Methods.
ELISA for Quantification of Receptor Surface Expression. HeLa cells were grown to Ϸ60% confluence on 24-well tissue culture dishes and transfected with wildtype Myc-mGluR5 or Myc-mGluR5 S901A. After 36 -48 h, cells were washed in modified HBSS and allowed to equilibrate for at least 30 min at 37°C. Cells were treated with 500 M L-glutamate for the indicated time intervals. The cells were washed, fixed with 4% paraformaldehyde in PBS for 5 min at room temperature, and washed again, and nonspecific binding was blocked with 1% BSA/PBS for 45 min. Cells were incubated with Myc antibody (9E10) diluted 1:1,000 in 1% BSA/PBS for 60 min, washed, and blocked again with 1% BSA/PBS for 15 min and incubated for 60 min with anti-mouse IgG-HRP (Amersham Biosciences) diluted 1:5,000 in 1% BSA. Cells were washed and incubated with the colorimetric horseradish peroxidase substrate O-phenylenediamine dihydrate (1 mg/ml; Sigma) in OPD buffer (50 mM citric acid, 65 mM sodium phosphate, and 0.03% hydrogen peroxide, pH 5.0) with gentle shaking for 12 min. An equal volume of 0.1N H 2SO4 was added to stop the reaction. The optical density of each well was determined by using a microplate reader at 492 nm. The value obtained for untransfected cells was subtracted as background optical density.
Receptor Trafficking in Neurons.
A fluorescence-based antibody uptake internalization assay was performed as described previously (36) , with some modifications. Cultured hippocampal neurons prepared from E18 Sprague-Dawley rats were transfected with Myc-mGluR5 (wild-type or S901A) and mRFP-CaM or mRFP alone by using Ca 2ϩ phosphate coprecipitation. After 2 days, Myc antibody was added to the media to label surface-expressed mGluR5 for 45 min. Neurons were washed with PBS twice and then treated with the group I mGluR agonist DHPG (100 M) for 30 min at 37°C or with conditioned media alone at room temperature. After washing with PBS, the cells were fixed with 4% paraformaldehyde/4% sucrose in PBS for 15 min. Neurons were incubated with Alexa 633-conjugated (red) anti-mouse secondary antibody (Molecular Probes) for 30 min at room temperature to label the surface receptors and were washed, followed by permeabilization with 0.25% Triton X-100 for 5 min. After blocking with 10% normal goat serum, neurons were incubated with Alexa 488-conjugated (green) anti-mouse secondary antibody (Molecular Probes) for 30 min to label intracellular pools of receptors. After washing with PBS, ProLong Antifade reagent (Molecular Probes) was applied to neurons before mounting. Images were analyzed with a ϫ40 objective on an LSM 510 confocal microscope (Zeiss). Alexa 488 dye was excited with a 488-nm Ar laser and appeared green. The Alexa 633 dye (excited with a 633 nm HeNe laser) was presented as red for clarification. mRFP (Invitrogen) was excited with a 543-nm HeNe laser and presented as white. No crosstalk between channels was detected under these settings. Series of optical sections were collected at intervals of 0.4 m. The figures show maximum projections. For quantitative analysis, images from three or four dendrites per neuron (at least 15 neurons per experiment) were collected, and the amount of internalization was measured based on the data collected in three independent experiments with MetaMorph 6.0 software (Universal Imaging Corp.). The values represent meansϮSEM. Significance was determined by using a Student's unpaired t test.
